Newsletter Sign-up

The residue of prescription drugs is finding its way back into the human body through drinking water systems. The issue raises questions about liability and whether drug makers could eventually be on the hook.

An overview of the current state of affairs in the liability insurance market for U.S. life sciences industry.

A listing of some of the nation's top biotech and life sciences companies, their risk managers, brokers, captives and risk management programs.

The U.S. Supreme Court's decision in Wyeth v. Levine will raise the costs for product liability litigation across a host of industries, according to legal experts, but insurance buyers aren't likely to feel its effects for now as there's still plenty of capacity in the market.

A musician suffers a horrible accident and her case makes it all the way to the U.S. Supreme Court.

The recent Wyeth v. Levine case could leave any industry regulated by federal law seeking shelter from the plaintiffs' bar.

A listing of some of the nation's top pharmaceutical companies and key metrics about their operations.

Big Pharma seems to be the target du jour of plaintiffs' attorneys. This product liability onslaught might not just be affecting the insurance market, but also the pharmaceutical companies' abilities to produce new, more effective drugs.

A listing of some of the nation's top pharmaceutical companies, their risk managers, brokers, captives and risk management programs.

The just-in-time manufacturing process has helped manufacturers maintain profit margins, but it has also eroded the safety margin built into supply chains.

A listing of some of the nation's top publicly traded manufacturing companies, their risk managers, brokers, captives and risk management programs.

The best commercial brokers in the business know their customers sometimes better than customers know themselves. So, just who belongs to this vaunted group of middlemen and women for the pharmaceuticals industry? Find out the 2011 Power Broker® results.

For all you Supreme Court junkies out there, here is the Court's ruling on the landmark Wyeth v. Levine case, as well as the briefs from both Wyeth and Levine.

Pharmaceutical risk managers--and anyone for that matter with product liability exposure--might want additional explanation on how state pre-emption will be affected by the Wyeth v. Levine case. Find it in the following blog posts:

Pharmaceuticals and Personal Care Products (PPCPs)in our drinking water have many governmental and environmental folks concerned. But manufacturers of those chemicals also also a little concerned about their PPCP liability.